Catriona Yale Akero Therapeutics, Inc. (AKRO) insider trading activity

Catriona Yale is Chief Development Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AKRO, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2022, when has been sold 5,000 shares (Common Stock) at a price of $37.99 per share, resulting in proceeds of $189,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Catriona Yale Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2022	SELL Open market or private sale	$189,950 $37.99 p/Share	5,000 Reduced 6.09%	77,073 Common Stock
Sep 13 2022	SELL Open market or private sale	$1,104,400 $27.61 p/Share	40,000 Reduced 32.77%	82,073 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$9,251 $8.03 p/Share	1,152 Added 0.93%	122,073 Common Stock
Oct 15 2021	SELL Open market or private sale	$274,500 $21.96 p/Share	12,500 Reduced 9.37%	120,921 Common Stock
Sep 15 2021	SELL Open market or private sale	$311,750 $24.94 p/Share	12,500 Reduced 8.57%	133,421 Common Stock
Aug 16 2021	SELL Open market or private sale	$187,900 $18.79 p/Share	10,000 Reduced 6.41%	145,921 Common Stock
Jul 15 2021	SELL Open market or private sale	$209,000 $20.9 p/Share	10,000 Reduced 6.03%	155,921 Common Stock

Jun 30 2020	BUY Grant, award, or other acquisition	$21,252 $17.07 p/Share	1,245 Added 0.75%	164,914 Common Stock

Catriona Yale

Chief Development Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Value

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Akero Therapeutics, Inc.

Track Activities on AKRO

Account